Trial Profile
A phase I/IIa study to investigate the safety and efficacy of the combination of AZD8186 and abiraterone acetate in patients with prostate cancer
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 28 Apr 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; AZD-8186 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2015 New trial record